Latest filing published 13 Dec 2021 for Foghorn Therapeutics Inc., €342k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Carl Decicco: trading record in brief
Carl Decicco, listed as senior executive, appears in our data through filings on Foghorn Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 27 October 2020 to 9 December 2021, the count stands at 2 filings.
Every open-market trade on record is a purchase: 1 purchase worth €75k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 option exercise.
Most recently, on 13 December 2021, the filings show an option exercise worth €342k in Foghorn Therapeutics Inc. The clock since the last published purchase (29 October 2020) now reads 2,201 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carl Decicco
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 104,310 shares@ US$3.72100.0% of flowCommon StockSEC:0001562180-21-007666:0
1 of 1 declaration